| 英文名稱 | Sophoraflavanone G |
|---|---|
| 中文名稱 | 苦參新醇F/苦參醇F/槐黃烷酮G/槐屬二氫黃酮G/苦參新醇/降苦參酮 |
| CAS號(hào) | 97938-30-2 |
| 分子式 | C25H28O6 |
| 分子量 | 424.49 |
| 熔點(diǎn) | 178-180 °C |
| 沸點(diǎn) | 659.3±55.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 7.66±0.40 | Condition: Most Acidic Temp: 25 °C |
| 英文名稱 | Sophoraflavanone G |
|---|---|
| 中文名稱 | 苦參新醇F/苦參醇F/槐黃烷酮G/槐屬二氫黃酮G/苦參新醇/降苦參酮 |
| CAS號(hào) | 97938-30-2 |
| 分子式 | C25H28O6 |
| 分子量 | 424.49 |
| 熔點(diǎn) | 178-180 °C |
| 沸點(diǎn) | 659.3±55.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 7.66±0.40 | Condition: Most Acidic Temp: 25 °C |
WKQ-0643354
中文名稱：苦參新醇F
中文別名：苦參醇F；槐黃烷酮G；槐屬二氫黃酮G；苦參新醇；降苦參酮
英文名稱：Sophoraflavanone G
英文別名：4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexenyl]-, (2S)- (9CI);4H-1-Benzopyran-4-one, 2-(2,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[5-methyl-2-(1-methylethenyl)-4-hexenyl]-, [S-(R*,S*)]-;(2S)-2-(2,4-Dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-8-[(2R)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-4H-1-benzopyran-4-one;(-)-Vexibinol;Kushenol F;Kushnol F;Norkurarinone;Sophoraflavanone G;Vexibinol;
分子式：C25H28O6
分子量：424.49
CAS號(hào)：97938-30-2
純度：HPLC≥98%
熔點(diǎn)：178-180 °C
沸點(diǎn)：659.3±55.0 °C | Condition: Press: 760 Torr
密度：1.266±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：7.66±0.40 | Condition: Most Acidic Temp: 25 °C
儲(chǔ)存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對(duì)照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請(qǐng)關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Integrated metabolomics and network pharmacology strategy for ascertaining the quality marker of flavonoids for Sophora flavescens | ||
| 來源：SCI：JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 作者：Lei Chen | 備注：影響因子：3.209 |
| 引用描述 | ||
Reference standards were used in this study, twenty-eight of them were self-made by our laboratory in the early stage [[16], [17], [18]], including 3′-hydroxy-daidzein, calycosin, trifolirhizin, genistein, maackiain, sophoraflavescenol, noranhydroicaritin, shandougenines B, kushenol C, leachianone G, liquiritigenin, 8-(3-hydroxymethyl-2-butenyl)-5,7,2′,4′-tetrahydroxyflavanone, 2′-hydroxy-isoxanthohumol, (2R)-3β,7,4′-trihydroxy-5-methoxy-8-prenylflavanone, (2R)-3α,7,4′-trihydroxy-5-methoxy-8-prenylflavanone, 4H-1-benzopyran-4-one,2-(4-hydroxyphenyl)-3,7-dihydroxy-5-methoxy-8-[5-methyl-2-(1-methylethenyl)-4-hexenyl], isoxanthohumol, kurarinol, kushenol N, kurarinone, isokurarinone, kushenol U, 2′-methoxykurarinone, norkurarinone, kushenol A, kushenol L, kuraridin, xanthohumol and biochanin A, kushenol B and kushenol M were purchased from Sichuan Weikeqi Biological Technology Co., Ltd (Sichuan China) and Wuhan Tianzhi Biotechnology Co., Ltd. (Wuhan, China), kushenol E and kushenol X were donated by Dr. YY Jiang from Beijing University of Chinese Medicine. The purity of the above standards is greater than 98 %. | ||
